Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 34,542 shares at $13.01 ($449K) on 2024-01-08, disclosed to the SEC on 2024-01-10.
Scheduled sale ($449k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.01 | 17,221 | $224K | 49.9% |
| 2 | $13.01 | 17,221 | $224K | 49.9% |
| 3 | $13.00 | 100 | $1K | 0.3% |
| Total | $13.01 avg | 34,542 | $449K | 100% |
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2023-11-21 | $41K | — | Filing → |